Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Toxicity”

435 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 435 results

Early research (Phase 1)Looking for participantsNCT04872166
What this trial is testing

BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

Who this might be right for
Advanced Solid TumorMetastatic Breast Cancer
Edgewood Oncology Inc. 112
Testing effectiveness (Phase 2)Study completedNCT01292356
What this trial is testing

Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response

Who this might be right for
Metastatic Colon Cancer
Poitiers University Hospital 28
Not applicableStudy completedNCT00106795
What this trial is testing

Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS

Who this might be right for
HIV InfectionsFatigueHIV Positive+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 82
Testing effectiveness (Phase 2)Study completedNCT01763307
What this trial is testing

Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI

Who this might be right for
Rash Due to Epidermal Growth Factor Receptor Inhibitors
Hadassah Medical Organization 18
Post-approval studies (Phase 4)Ended earlyNCT00699101
What this trial is testing

Using the Conture® Multi-Lumen Balloon to Deliver Accelerated Partial Breast Brachytherapy

Who this might be right for
Breast Cancer
SenoRx, Inc. 342
Large-scale testing (Phase 3)UnknownNCT05595109
What this trial is testing

Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

Who this might be right for
Breast CancerPeripheral NeuropathyCardiac Toxicities+2 more
Tanta University 56
Not applicableLooking for participantsNCT04075305
What this trial is testing

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Who this might be right for
OncologyBreast CancerProstate Cancer+35 more
UMC Utrecht 8,000
Not applicableStudy completedNCT03471741
What this trial is testing

Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer

Who this might be right for
Breast CancerRadiation Toxicity
IRCCS Azienda Ospedaliero-Universitaria di Bologna 451
Early research (Phase 1)Study completedNCT00001676
What this trial is testing

Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

Who this might be right for
GlomerulonephritisLupus NephritisSystemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15
Not applicableUnknownNCT06414343
What this trial is testing

LATe TreatmENT Related Toxicity in Melanoma (LATENT)

Who this might be right for
Melanoma
Royal Marsden NHS Foundation Trust 400
Not applicableStudy completedNCT01070121
What this trial is testing

Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository

Who this might be right for
Rheumatoid Arthritis
University of Alabama at Birmingham 200
Testing effectiveness (Phase 2)Looking for participantsNCT05559164
What this trial is testing

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Who this might be right for
Cardiac ToxicityEarly-stage Breast Cancer
Rutgers, The State University of New Jersey 60
Not applicableNot Yet RecruitingNCT07527819
What this trial is testing

Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Peter MacCallum Cancer Centre, Australia 75
Testing effectiveness (Phase 2)Study completedNCT01262469
What this trial is testing

Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.

Who this might be right for
Metastatic Breast Cancer70 Years Old Patients and OverAfter One Line of Chemotherapy With Trastuzumab
UNICANCER 4
Post-approval studies (Phase 4)Study completedNCT00158041
What this trial is testing

Subcutaneous Amifostine Safety Study

Who this might be right for
Head and Neck CancerLung CancerLymphoma
Mt. Sinai Medical Center, Miami 452
Testing effectiveness (Phase 2)Study completedNCT00080353
What this trial is testing

Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 58
Not applicableUnknownNCT00122239
What this trial is testing

Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers

Who this might be right for
Breast CancerGliomaProstate Cancer+3 more
AHS Cancer Control Alberta 13
Not applicableLooking for participantsNCT05984888
What this trial is testing

Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer

Who this might be right for
Breast Cancer
Ohio State University Comprehensive Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT03448731
What this trial is testing

Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA)

Who this might be right for
Skin Toxicity
Fundacion CRIS de Investigación para Vencer el Cáncer 34
Not applicableActive Not RecruitingNCT05912231
What this trial is testing

Ultrahypofractionation and Normal Tissue Toxicity

Who this might be right for
Breast CancerBreast Cancer FemaleBreast Cancer Stage II+2 more
Massachusetts General Hospital 60
Next Page